Back to top

Image: Bigstock

Henry Schein, Inc.

Read MoreHide Full Article

Post a better-than-expected first quarter performance on balanced segmental growth, we are impressed with Henry Schein's strong share gains in the North American and overseas markets. Despite the better-than-expected revenue performance in the last-reported quarter, we are disappointed with the year-over-year deterioration in Henry Schein's gross and operating margin due to higher costs and expenses. We currently await the completion of the company’s global Animal Health business' planned spin-off. This business contributes nearly 30% to the company’s topline. The spin off is expected to bring in major changes to Henry Schein’s overall operating results. On the flip side, pricing pressure and tough competition are major woes. Overall, in the past three months, Henry Schein has outperformed the broader industry.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Henry Schein, Inc. (HSIC) - free report >>

Published in